Anti-transforming growth factor Beta (TGF-.beta.) treated stem cell composition and method

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6627191
SERIAL NO

09490520

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to stem cell compositions comprising anti-TGF-.beta. treated stem cells which are viable for at least 14 days in culture without replication or differentiation and methods for rapid and long term in vitro hematopoiesis and in vivo hematopoietic reconstitution using such anti-TGF-.beta. treated stem cells.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SEATTLE BIOMEDICAL RESEARCH INSTITUTE307 WESTLAKE AVENUE NORTH SUITE 500 SEATTLE WA 98109

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bartelmez, Stephen H Seattle, WA 7 112
Ruscetti, Frank New Market, MD 2 18
Sitnicka, Ewa Lund, SE 2 18

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation